跳至主要内容
临床试验/NL-OMON43511
NL-OMON43511已完成不适用

Circulating tumour cells by diagnostic leukapheresis mirror primary tumour heterogeneity in non-small cell lung cancer - CANCER-ID UMCG CTC

niversitair Medisch Centrum Groningen0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with a histologically proven pulmonary malignancy (all disease stages)
  • Performance status 0-2
  • Patients using anticoagulants such as fraxodi or acenocoumarol are allowed, unless they have had recent hemorrhagic events
  • Written informed consent

排除标准

  • Patients with insufficient peripheral venes to undergo leukapheresis
  • Haemorrhagic diathesis: recent CVA, major bleeding, ulcus duodeni
  • Cardiac failure, LVEF<40%
  • No growth factors are allowed

研究者

相似试验

Circulating tumour cells by diagnostic leukapheresis... | 临床试验